Targeting chemokines and chemokine receptors in melanoma and other cancers
Journal Title
Frontiers in Immunology
Publication Type
Journal Article
Abstract
The tumor microenvironment is highly heterogeneous. It is composed of a diverse array of immune cells that are recruited continuously into lesions. They are guided into the tumor through interactions between chemokines and their receptors. A variety of chemokine receptors are expressed on the surface of both tumor and immune cells rendering them sensitive to multiple stimuli that can subsequently influence their migration and function. These features significantly impact tumor fate and are critical in melanoma control and progression. Indeed, particular chemokine receptors expressed on tumor and immune cells are strongly associated with patient prognosis. Thus, potential targeting of chemokine receptors is highly attractive as a means to quench or eliminate unconstrained tumor cell growth.
Publisher
Frontiers Media
Research Division(s)
Molecular Immunology
PubMed ID
30420855
Open Access at Publisher's Site
https://doi.org/10.3389/fimmu.2018.02480
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2018-11-20 09:12:49
Last Modified: 2018-11-20 12:01:01
An error has occurred. This application may no longer respond until reloaded. Reload 🗙